Lynn Webster is careful to distinguish between promising and proven. For instance, the large veteran study is observational and doesnt establish that GLP-1s directly caused the reductions in opioid cravings
This is especially relevant for people with hormone optimization protocols who may be taking thyroid medications, hormone replacement therapy, or other compounds that depend on consistent absorption patterns
The majority of reports were submitted by consumers ( n = 6,577, 79.82%) and physicians ( n = 694, 8.42%)
According to Pfizer's latest preliminary results from Phase 2b clinical trials, after adjustment for placebo, the average weight loss rate of Danuglipron at 32 weeks ranged from -8% to -13%, and at 26 weeks it ranged from -5% to -9.5%
What Year Does the Ozempic Patent Expire and Why Does It Matter for You
Bmj 374, 2103